---------------------------------
The Pharmacist e-Link™ Continuing Education Center is designed to provide you with expanded online access to the highest quality of continuing education on a complimentary basis, through the convenience of the Velocity™ Online Learning Management System. |
---------------------------------
---------------------------------
Need Help logging into the Pharmacicst e-Link site?
Click Here for Registration and
Login Information
---------------------------------
 |
 |
 Pharmacist e-Link CE Spotlight |
 |
 |
The Pharmacist's Role in the Medication Therapy Management of Chronic Pain
Managing your patients with chronic pain critical to ensuring the best patient outcomes, this session will bring you vital information you need to know to give these pharmacy patients the best possible care and greatly improve their quality of life.
This program is supported through an educational grant from Purdue Pharma, L.P. |
 |
The Skinny on Fatty Acids: The Efficacy of Omega-3s
It is important that pharmacists are aware of the appropriate treatment options when advising patients with hypertriglyceridemia or at risk for coronary heart disease. This program will provide information regarding available types and sources of omega-3 fatty acids.
This program is supported by an educational grant from Reliant Pharmaceuticals. |
|
 |
Emerging Trends in HIV Combination Therapy: The Pharmacology and the Pharmacist
Because of their unique accessibility and extensive knowledge about medications, pharmacists fulfill a major role in ensuring that patients with HIV/AIDS understand and properly take their medicines; non-compliance with therapeutic regimens remains a particularly significant challenge in this patient population. Pharmacists are in an excellent position to provide compliance counseling at the point-of-care, as well as to monitor continued compliance over time, including, if necessary, notifying prescribers about potential therapy problems.
This program is supported by an unrestricted educational grant from Roche Laboratories. |
 |
Common Misconceptions with Bioequivalence and Interchangeability
This CE program examines the bioequivalence and interchangeability of drugs. Since several factors can influence the bioavailability of drugs, this activity highlights instances where sub-therapeutic responses, alterations in outcomes, or adverse events can be consequences of pharmacokinetic interactions. |
 |
Current Considerations in Managing Neutropenia in Breast Cancer Patients
This activity is intended for physicians, physician assistants, pharmacists, nurses and certified case managers who treat or manage treatment resources for cancer patients receiving chemotherapy who are at risk for neutropenia and its complications.
This activity is made possible by an educational grant from Amgen Inc. |
 |
Novel Therapies to Reduce Cardiometabolic Risk Factors
New and novel therapies are emerging that effect the endocannabinoid system (ECS). These therapies impact on the regulation of food intake and fat accumulation, as well as lipid and glucose metabolism.
This activity has been developed and provided by The GMR Group-Health Insights and is supported by an educational grant from Sanofi-Aventis. |
 |
The Health Professional's Role in Formulary Management of Medicare Part D Benefits
Pharmacists are confronting many challenges with the new Medicare Prescription Drug Benefit. Among the most time consuming are formulary management, prior authorization requirements, step therapy protocols, and tight formularies. Most Medicare beneficiaries will encounter new formulary requirements, so preparation will be key for pharmacists during their patient's transition to Medicare Part D when they will be in the crucial position of interacting between the plan, prescriber, and patient to lessen any delays in drug coverage.
This activity is supported by an educational grant from Boehringer Ingelheim Pharmaceuticals, Inc. |
|
|
